Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Steve Rees
Institution:
AstraZeneca (United Kingdom)
Observed institutions:
AstraZeneca (United Kingdom),
GlaxoSmithKline (United Kingdom),
University of Exeter,
University of Cambridge,
GlaxoSmithKline Research & Development Limited (United Kingdom)
OpenAlex ID:
A5113656912
Impact of a five-dimensional framework on R&D productivity at AstraZeneca
2018
·
Paul Morgan
, Dean G. Brown
, et al.
·
Nature Reviews Drug Discovery
·
451
Screening β-Arrestin Recruitment for the Identification of Natural Ligands for Orphan G-Protein–Coupled Receptors
2013
·
Craig Southern
, Jennifer M. Cook
, et al.
·
SLAS DISCOVERY
·
180
PDF
Simultaneous inhibition of DNA-PK and Polϴ improves integration efficiency and precision of genome editing
2023
·
Sandra Wimberger
, Nina Akrap
, et al.
·
Nature Communications
·
132
PDF
Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission
2022
·
Dinesh Aggarwal
, Ben Warne
, et al.
·
Nature Communications
·
54
PDF
Effects of a range of β2 adrenoceptor agonists on changes in intracellular cyclic AMP and on cyclic AMP driven gene expression in cultured human airway smooth muscle cells
1999
·
Mark G H Scott
, Caroline Swan
, et al.
·
British Journal of Pharmacology
·
32
PDF
Towards a hit for every target
2015
·
Steve Rees
, Philip Gribbon
, et al.
·
Nature Reviews Drug Discovery
·
28
Heat inactivation of clinical COVID-19 samples on an industrial scale for low risk and efficient high-throughput qRT-PCR diagnostic testing
2022
·
Oona Delpuech
, Julie A. Douthwaite
, et al.
·
Scientific Reports
·
19
PDF
The BlueScreen-384 Assay as an Indicator of Genotoxic Hazard Potential in Early-Stage Drug Discovery
2012
·
Kate Simpson
, Nicola Bevan
, et al.
·
SLAS DISCOVERY
·
17
PDF
A Combined Human in Silico and CRISPR/Cas9-Mediated in Vivo Zebrafish Based Approach to Provide Phenotypic Data for Supporting Early Target Validation
2022
·
Matthew J. Winter
, Yosuke Ono
, et al.
·
Frontiers in Pharmacology
·
11
PDF
Feasibility and efficacy of mass testing for SARS-CoV-2 in a UK university using swab pooling and PCR
2021
·
Ben Warne
, Jessica Enright
, et al.
·
Research Square
·
10
PDF
The Promise of Open Innovation in Drug Discovery: An Industry Perspective
2015
·
Steve Rees
·
Future Medicinal Chemistry
·
6
Improving the efficiency and effectiveness of an industrial SARS-CoV-2 diagnostic facility
2022
·
Julie A. Douthwaite
, Christopher A. Brown
, et al.
·
Scientific Reports
·
4
PDF
Optimised genome editing for precise DNA insertion and substitution using prime editors in zebrafish
2025
·
Yosuke Ono
, Martin Peterka
, et al.
·
eLife
·
3
Optimised genome editing for precise DNA insertion and substitution using Prime Editors in zebrafish
2025
·
Yosuke Ono
, Martin Peterka
, et al.
·
eLife
·
2
An iteratively optimised process for improving the efficiency and effectiveness of an industrial SARS-CoV-2 diagnostic facility
2021
·
Julie A. Douthwaite
, Christopher A. Brown
, et al.
·
Research Square
·
2
PDF
Genome Editing in Drug Discovery
2022
·
Steve Rees
·
1
Author response: Optimised genome editing for precise DNA insertion and substitution using prime editors in zebrafish
2026
·
Yosuke Ono
, Martin Peterka
, et al.
PDF
Reviewer #3 (Public review): Optimised genome editing for precise DNA insertion and substitution using Prime Editors in zebrafish
2025
·
Yosuke Ono
, Martin Peterka
, et al.
Show more works
View as search
Works count:
18
Citation count:
952
H-index:
10
I10-index:
10
Year
Topic
Type